seed
Stage
4
Investors
About
Samphire Neuroscience is developing a digital therapeutic that combines neurostimulation with AI-driven personalised care to treat Premenstrual Dysphoric Disorder (PMDD).
Explore Samphire Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.